A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy (Q44928172)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy |
scientific article |
Statements
1 reference
A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy (English)
1 reference
Carolina M Casellini
1 reference
Patricia M Barlow
1 reference
Amanda L Rice
1 reference
Melissa Casey
1 reference
Kathryn Simmons
1 reference
Gary Pittenger
1 reference
Edward J Bastyr
1 reference
Anne M Wolka
1 reference
Aaron I Vinik
1 reference
1 April 2007
1 reference
1 reference
Identifiers
1 reference